Thursday, January 27, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



South Africa approves use of J&J Covid-19 booster

South Africa approves use of J&J Covid-19 booster

South Africa approves use of J&J Covid-19 booster

Pretoria, Dec 23 (Prensa Latina) The South African Health Products Regulatory Authority (SAHPRA) approved a second booster dose of the Johnson & Johnson (J&J) Covid-19 vaccine.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to the entity, the additional dose will be administered to people over 18 years of age who received the initial single dose.

As stipulated, the second J&J dose should be given at least two months after the first one.

SAHPRA has also decided to approve the mixing and matching of different Covid-19 vaccines.

Those who received Pfizer-BioNTech’s two-dose vaccine may also be eligible to receive a third dose of J&J’s vaccine, in what is known as a heterologous boost, SAHPRA says.

At the moment, the South African Ministry of Health has not ruled on this option.

The dosing interval for the heterologous booster dose (J&J) will be six months after Pfizer’s second injection, the regulator said.

Over 6.8 million people, including healthcare workers, have already been vaccinated in South Africa with the J&J vaccine.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.